The US Food and Drug Administration is backing the extension of a copyright enforcement policy that allows access to medical device software, including for cybersecurity purposes.
Suzanne Schwartz, director of Office of Strategic Partnerships and Technology Innovation (OST) at FDA, issued a letter in June expressing the agency’s continued support of the Digital Millennium Copyright
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?